Clinical Context
A typical scenario involves an adult patient with a complement-mediated disorder for which pozelimab-bbfg is indicated (for example, a rare complement C5-mediated disease). A specialist (hematologist, immunologist, or nephrologist) prescribes intravenous administration of J9376 (pozelimab-bbfg) dosed in milligrams; the facility schedules an infusion visit in an outpatient infusion center or hospital outpatient department. Prior to infusion the clinical team verifies indications, recent labs (CBC, renal function), vital signs, and allergy history, obtains informed consent, and documents baseline symptoms. Nursing prepares the calculated dose drawn from the single-use vial and performs standard intravenous access and administration per product labeling, monitoring for infusion reactions during and for a period after infusion. Documentation includes drug name and dose in mg, lot number, route, date and time of administration, infusion duration, premedications if given, and any adverse events. Billing uses the HCPCS level II code J9376 reported in units corresponding to milligrams administered, with appropriate modifier(s) to indicate payer-specific circumstances or service details. Typical sites of service are outpatient infusion centers, hospital outpatient departments, or physician offices with infusion capabilities. Common clinical workflow steps: referral/prescription, prior authorization, pre-infusion assessment and labs, infusion administration and monitoring, post-infusion documentation and discharge instructions, and periodic follow-up for effectiveness and safety monitoring.